Pelvic lymph node status prediction in melanoma patients with inguinal lymph node metastasis

The extent of the groin lymph node (LN) dissection for melanoma is still being debated, particularly in the case of micrometastasis (sentinel lymph node positive). We tested the predictive values of the criteria for pelvic dissection currently suggested by national guidelines (number of positive inguinal LN, Cloquet’s LN status, and preoperative computed tomographic scan) and the inguinal lymph node ratio (LNR, the ratio between metastatic and excised LNs) to identify patients with pelvic metastasis. We analyzed the predictive values of the above-mentioned criteria in 157 patients who underwent an ilioinguinal dissection, with a focus on their negative predictive values (NPV), which might help identify low-risk patients who might safely avoid pelvic dissection, pelvic dissection reduction, and error rate. Forty-four (26.7%) patients had pelvic LN metastasis. In patients with micrometastasis (17.3% had pelvic LN metastasis), LNR less than 0.1 and Cloquet’s LN status achieved clinically relevant NPV (95.7 and 95.5%, respectively) and pelvic dissection reduction (38.4 and 84.6%, respectively), whereas the error rate was 1.7 and 3.0%, respectively. Lower NPVs were observed for number of positive inguinal LNs (88.6%) and computed tomographic scan (78.4%). Accuracy was enhanced when these criteria were considered in multivariable models. In patients with macrometastasis (36.8% had pelvic LN metastasis), LNR and current selection criteria achieved low NPVs and a high error rate. Avoiding pelvic dissection may be safe in sentinel lymph node-positive patients with LNR less than 0.1. The prediction of pelvic metastasis seems to be less accurate for patients with clinically positive LNs.

[1]  B. Pockaj,et al.  Limitations of Lymph Node Ratio, Evidence-Based Benchmarks, and the Importance of a Thorough Lymph Node Dissection in Melanoma , 2013, Annals of Surgical Oncology.

[2]  A. Eggermont,et al.  The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases. , 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[3]  G. Botti,et al.  Superficial and deep lymph node dissection for stage III cutaneous melanoma: clinical outcome and prognostic factors , 2013, World Journal of Surgical Oncology.

[4]  K. Shannon,et al.  Surgeons’ Opinions on Lymphadenectomy in Melanoma Patients with Positive Sentinel Nodes: A Worldwide Web-Based Survey , 2012, Annals of Surgical Oncology.

[5]  E. Bastiaannet,et al.  Therapeutic Lymph Node Dissection in Melanoma: Different Prognosis for Different Macrometastasis Sites? , 2012, Annals of Surgical Oncology.

[6]  Carlo Riccardo Rossi,et al.  Maximizing the clinical usefulness of a nomogram to select patients candidate to sentinel node biopsy for cutaneous melanoma. , 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[7]  S. Mocellin,et al.  Validation of the prognostic value of lymph node ratio in patients with cutaneous melanoma: a population-based study of 8,177 cases. , 2011, Surgery.

[8]  L. Haydu,et al.  Quality Assurance Parameters and Predictors of Outcome for Ilioinguinal and Inguinal Dissection in a Contemporary Melanoma Patient Population , 2011, Annals of Surgical Oncology.

[9]  K. Delman,et al.  Inguinopelvic Lymphadenectomy Following Positive Inguinal Sentinel Lymph Node Biopsy in Melanoma: True Frequency of Synchronous Pelvic Metastases , 2011, Annals of Surgical Oncology.

[10]  A. Eggermont,et al.  Therapeutic Surgical Management of Palpable Melanoma Groin Metastases: Superficial or Combined Superficial and Deep Groin Lymph Node Dissection , 2011, Annals of Surgical Oncology.

[11]  A. Spillane,et al.  A Pilot Study Reporting Outcomes for Melanoma Patients of a Minimal Access Ilio-inguinal Dissection Technique Based on Two Incisions , 2011, Annals of Surgical Oncology.

[12]  Yan Xing,et al.  Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis. , 2011, Journal of the National Cancer Institute.

[13]  A. Spillane,et al.  Lymph Node Ratio Provides Prognostic Information in Addition to American Joint Committee on Cancer N Stage in Patients With Melanoma, Even If Quality of Surgery Is Standardized , 2011, Annals of surgery.

[14]  V. Sondak,et al.  Routine biopsy of cloquet's node is of limited value in sentinel node positive melanoma patients , 2010, Journal of surgical oncology.

[15]  Simone Mocellin,et al.  Sentinel Node Status Prediction by Four Statistical Models: Results From a Large Bi-Institutional Series (n = 1132) , 2009, Annals of surgery.

[16]  O. Nieweg,et al.  Evaluation of Lymphatic Drainage Patterns to the Groin and Implications for the Extent of Groin Dissection in Melanoma Patients , 2009, Annals of Surgical Oncology.

[17]  A. Carbone,et al.  Radical dissection after positive groin sentinel biopsy in melanoma patients: rate of further positive nodes , 2009, Melanoma research.

[18]  K. Shannon,et al.  Proposed Quality Standards for Regional Lymph Node Dissections in Patients With Melanoma , 2009, Annals of surgery.

[19]  J. Thomas,et al.  ILIOINGUINAL LYMPH NODE DISSECTION FOR PALPABLE METASTATIC MELANOMA TO THE GROIN , 2008, ANZ journal of surgery.

[20]  V. Rousson,et al.  Morbidity and Recurrence After Completion Lymph Node Dissection Following Sentinel Lymph Node Biopsy in Cutaneous Malignant Melanoma , 2008, Annals of surgery.

[21]  O. Nieweg,et al.  Tumor-Positive Sentinel Node Biopsy of the Groin in Clinically Node-Negative Melanoma Patients: Superficial or Superficial and Deep Lymph Node Dissection? , 2008, Annals of Surgical Oncology.

[22]  S. Mocellin,et al.  Factors Predictive of Nonsentinel Lymph Node Involvement and Clinical Outcome in Melanoma Patients With Metastatic Sentinel Lymph Node , 2008, Annals of Surgical Oncology.

[23]  R. Elashoff,et al.  Sentinel-node biopsy or nodal observation in melanoma. , 2006, The New England journal of medicine.

[24]  D. Morton,et al.  Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection. , 2006, Archives of surgery.

[25]  A. Cochran,et al.  Tumour–induced immune modulation of sentinel lymph nodes , 2006, Nature Reviews Immunology.

[26]  Alessandro Ambrosi,et al.  Support Vector Machine Learning Model for the Prediction of Sentinel Node Status in Patients With Cutaneous Melanoma , 2006, Annals of Surgical Oncology.

[27]  L. Mack,et al.  Controversies in the management of metastatic melanoma to regional lymphatic basins , 2004, Journal of surgical oncology.

[28]  R. Scolyer,et al.  The Prognostic Importance of Tumor Mitotic Rate Confirmed in 1317 Patients With Primary Cutaneous Melanoma and Long Follow-Up , 2004, Annals of Surgical Oncology.

[29]  Yuting Zhang,et al.  Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma , 2003, Cancer.

[30]  A. Hart,et al.  The Value of Cloquet’s Node in Predicting Melanoma Nodal Metastases in the Pelvic Lymph Node Basin , 2001, Annals of Surgical Oncology.

[31]  J. Thomas,et al.  Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma , 2000, The British journal of surgery.

[32]  J. Thomas,et al.  Combined inguinal and pelvic lymph node dissection for stage III melanoma , 1999, The British journal of surgery.

[33]  D. Coit,et al.  Extent of lymph node dissection in melanoma of the trunk or lower extremity. , 1989, Archives of surgery.

[34]  K. Aigner,et al.  Diagnostic excision of the Rosenmüller's node. Screening for occult metastases before elective regional lymph node dissection in patients with lower limb melanoma? , 1988, Cancer.

[35]  Michael E. Egger,et al.  The lymph node ratio has limited prognostic significance in melanoma. , 2013, The Journal of surgical research.

[36]  C. Slingluff,et al.  Surgical resection for bulky or recurrent axillary metastatic melanoma , 2012, Journal of surgical oncology.

[37]  T. Hyslop,et al.  Lymph node ratio is an important and independent prognostic factor for patients with stage III melanoma , 2012, Journal of surgical oncology.

[38]  S. Mocellin,et al.  N-Ratio: a Novel Independent Prognostic Factor for Patients with Stage-III Cutaneous Melanoma , 2007, Annals of Surgical Oncology.

[39]  C. Neumann,et al.  Superficial inguinal and radical ilioinguinal lymph node dissection in patients with palpable melanoma metastases to the groin--an analysis of survival and local recurrence. , 2001, Acta oncologica.